Intolerancia a la histamina (Spanish Wikipedia)

Maintz, Laura; Bieber, Thomas; Novak, Natalija (25 de diciembre de 2006). «Die verschiedenen Gesichter der Histaminintoleranz: Konsequenzen für die Praxis». Deutsches Ärzteblatt 103 (51–52): A-3477 / B-3027 / C-2903. Consultado el 3 de junio de 2019.
Wilhelm, T. (15 de junio de 2007). «Tabakrauch ist bedeutende Histaminquelle». Deutsches Ärzteblatt. Köln 104.2007: A 1768.

archive.org

Maintz, L.; Novak, N. (2007). «Histamine and histamine intolerance.». American Journal of Clinical Nutrition 85 (5): 1185-96. PMID 17490952. doi:10.1093/ajcn/85.5.1185.

Maintz, L.; Novak, N. (2007). «Histamine and histamine intolerance.». American Journal of Clinical Nutrition 85 (5): 1185-96. PMID 17490952. doi:10.1093/ajcn/85.5.1185.
Moon TC, Befus AD, Kulka M (2014). «Mast cell mediators: their differential release and the secretory pathways involved». Front Immunol 5: 569. PMC 4231949. PMID 25452755. doi:10.3389/fimmu.2014.00569. «This release of pre-formed mediators enables not only rapid anaphylactic reactions and allergic responses but also initiates recruitment of leukocytes to sites of pathogen invasion, activation of innate immune processes, and inflammatory responses (1). ... Two types of degranulation have been described for MC: piecemeal degranulation (PMD) and anaphylactic degranulation (AND) (Figures 1 and 2). Both PMD and AND occur in vivo, ex vivo, and in vitro in MC in human (78–82), mouse (83), and rat (84). PMD is selective release of portions of the granule contents, without granule-to-granule and/or granule-to-plasma membrane fusions. ... In contrast to PMD, AND is the explosive release of granule contents or entire granules to the outside of cells after granule-to-granule and/or granule-to-plasma membrane fusions (Figures 1 and 2).»

Figure 1: Mediator release from mast cells

Figure 2: Model of genesis of mast cell secretory granules

Figure 3: Lipid body biogenesis

Table 2: Stimuli-selective mediator release from mast cells

«Histamine Intolerance». Healthline. 13 de agosto de 2018. Consultado el 1 de abril de 2021.

lowhistamineeats (2 de junio de 2021). «Do I Have a Chocolate Intolerance (or Chocolate Allergy)?». Low Histamine Eats (en inglés estadounidense). Consultado el 24 de diciembre de 2021.

Maintz, L.; Novak, N. (2007). «Histamine and histamine intolerance.». American Journal of Clinical Nutrition 85 (5): 1185-96. PMID 17490952. doi:10.1093/ajcn/85.5.1185.
Moon TC, Befus AD, Kulka M (2014). «Mast cell mediators: their differential release and the secretory pathways involved». Front Immunol 5: 569. PMC 4231949. PMID 25452755. doi:10.3389/fimmu.2014.00569. «This release of pre-formed mediators enables not only rapid anaphylactic reactions and allergic responses but also initiates recruitment of leukocytes to sites of pathogen invasion, activation of innate immune processes, and inflammatory responses (1). ... Two types of degranulation have been described for MC: piecemeal degranulation (PMD) and anaphylactic degranulation (AND) (Figures 1 and 2). Both PMD and AND occur in vivo, ex vivo, and in vitro in MC in human (78–82), mouse (83), and rat (84). PMD is selective release of portions of the granule contents, without granule-to-granule and/or granule-to-plasma membrane fusions. ... In contrast to PMD, AND is the explosive release of granule contents or entire granules to the outside of cells after granule-to-granule and/or granule-to-plasma membrane fusions (Figures 1 and 2).»

Figure 1: Mediator release from mast cells

Figure 2: Model of genesis of mast cell secretory granules

Figure 3: Lipid body biogenesis

Table 2: Stimuli-selective mediator release from mast cells

«Tissue Expression of HNMT - Summary - Protein Atlas». Tissue Expression of HNMT - Summary - Protein Atlas. Consultado el 3 de junio de 2019.
«Tissue Expression of AOX1 - Summary - The Human Protein Atlas». Consultado el 3 de junio de 2019.